In Focus

Highlights

Montreal Protocol parties achieve complete phase-out of ozone-depleting CFCs

Parties to the Montreal Protocol on Substances that Deplete the Ozone Layer will achieve the final phase-out of ozone-depleting chlorofluorocarbons (CFCs) this year with the phase-out of CFCs used in metered-dose inhalers (MDIs).

More than 98% of the CFCs used in MDIs have already been phased out, and will disappear completely in 2016, a significant milestone following 30 years of concerted global action to protect the ozone layer.

Affordable CFC-free alternatives for all inhaled treatments have been developed over the last 20 years, and are now available worldwide.

In 1996, when CFC-based aerosols were phased out in developed countries, CFC-free replacement inhalers were not available for the hundreds of millions of patients with asthma/chronic obstructive pulmonary disease worldwide who relied on them, and so a temporary exemption was allowed.  MORE

Latest Documents

  • OEWG-38 : Annotations to the provisional agenda - UNEP/OzL.Pro.WG.1/38/1/Add.1 - Advance copy ( E )
  • ExMOP3 : Issues for discussion by and information for the attention of the Third Extraordinary Meeting of the Parties to the Montreal Protocol - UNEP/OzL.Pro.EXMOP.3/2 - Advance copy ( E )
  • OEWG-38 : Issues for discussion by and information for the attention of the Open-ended Working Group of the Parties to the Montreal Protocol at its thirty-eighth meeting: addendum - Advance copy ( E )
  • OEWG-38 : Key activities and initiatives of the Secretariat of relevance to the Montreal Protocol - UNEP/OzL.Pro.WG.1/38/INF/2 ( E )
  • OEWG-37-Resumed : OEWG-38: ExMOP3: Consolidation of the amendment proposals submitted by parties to the Montreal Protocol - UNEP/OzL.Pro.WG.1/resumed.37/INF/1 - UNEP/OzL.Pro.WG.1/38/INF/1 - UNEP/OzL.Pro.ExMOP/3/INF/1 ( E )
  • OEWG-38 : Issues for discussion by and information for the attention of the Open-ended Working Group of the Parties to the Montreal Protocol at its thirty-eighth meeting - UNEP/OzL.Pro.WG.1/38/2 (A C E F R S)